Group One Trading
IDYA icon

Group One Trading’s IDEAYA Biosciences IDYA Stock Holding History

Group One Trading’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Sell
4,137
-3,855
-48% -$118K ﹤0.01% 4503
2026
Q1 		$266K Buy
7,992
+7,524
+1,608% +$252K ﹤0.01% 3888
2025
Q4 		$16.2K Sell
468
-400
-46% -$12.8K ﹤0.01% 6514
2025
Q3 		$23.6K Buy
868
+145
+20% +$3.51K ﹤0.01% 6572
2025
Q2 		$15.2K Sell
723
-1,648
-70% -$31.6K ﹤0.01% 6444
2025
Q1 		$38.8K Buy
2,371
+2,100
+775% +$44.7K ﹤0.01% 5350
2024
Q4 		$6.96K Buy
271
+263
+3,288% +$7.45K ﹤0.01% 6274
2024
Q3 		$253 Hold
8
– – ﹤0.01% 6442
2024
Q2 		$281 Buy
+8
New +$317 ﹤0.01% 6503
2023
Q3 		– Sell
-720
Closed -$18.3K – 7927
2023
Q2 		$16.9K Buy
+720
New +$14.8K ﹤0.01% 6090
2021
Q4 		– Sell
-518
Closed -$13K – 8477
2021
Q3 		$13K Buy
518
+218
+73% +$5.09K ﹤0.01% 7384
2021
Q2 		$6K Buy
+300
New +$6.16K ﹤0.01% 7695

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Group One Trading's IDYA Position: Q2 2026 in Review

Group One Trading reduced its IDEAYA Biosciences (IDYA) stake by 48% in Q2 2026, selling an estimated $118K and leaving 4,137 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #4503.

Group One Trading first reported a position in IDYA in Q2 2021 and has held it in 12 quarters since. The position peaked at $266K in Q1 2026. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Group One Trading held 4,137 shares of IDEAYA Biosciences worth $154K as of Q2 2026.
  • Group One Trading sold 3,855 IDEAYA Biosciences shares in Q2 2026, an estimated $118K.
  • IDEAYA Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4503 holding.
  • Group One Trading first reported a position in IDEAYA Biosciences in Q2 2021 and has held it in 12 quarters since.
  • Group One Trading's IDEAYA Biosciences position peaked at $266K in Q1 2026.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.